- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
This is a challenging time to be running a drug maker. To be sure, there is plenty of positive news. Congress heeded the call to pass legislation for speeding drug approvals. The Trump
administration installed a Food and Drug Administration commissioner who is sympathetic to industry. More innovative medicines are finding their way to patients. And despite criticism over
pricing, Congress has not taken any steps that might displease drug makers. STAT+ Exclusive Story Already have an account? Log in THIS ARTICLE IS EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS
ARTICLE — PLUS DAILY COVERAGE AND ANALYSIS OF THE PHARMA INDUSTRY — BY SUBSCRIBING TO STAT+. Already have an account? Log in Individual plans Group plans View All Plans To read the rest of
this story subscribe to STAT+. Subscribe
